Neurological disorders

Published on 21/03/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2736 times

Neurological disorders

The central nervous system comprises 100 000 million neurones and when it malfunctions it has the potential to generate a wide spectrum of clinical problems. The site of the dysfunctional neurones determines the nature of the problem, which may involve impaired movement, vision, hearing, sensory perception, memory or consciousness. Classifying this wide range of symptom complexes can be problematic.

Headache

Headache is a frequent reason for older children and adolescents to consult a doctor. The International Headache Society (IHS) has devised a classification, as shown in Box 27.1, which defines:

Primary headaches

Tension-type headache

This is a symmetrical headache of gradual onset, often described as tightness, a band or pressure. There are usually no other symptoms.

Migraine with aura

Accounts for 10% of migraine. The headache is preceded by an aura (visual, sensory or motor), although the aura may occur without a headache. Features are the absence of problems between episodes and the frequent presence of premonitory symptoms (tiredness, difficulty concentrating, autonomic features, etc.).

The most common aura comprises visual disturbance, which may include:

Rarely, there are unilateral sensory or motor symptoms.

Episodes usually last for a few hours, during which time children often prefer to lie down in a quiet, dark place. Sleep often relieves the bout.

Symptoms of tension-type headache or a migraine often overlap. They are probably part of the same pathophysiological continuum, with evidence that both result from primary neuronal dysfunction, including channelopathies, with vascular phenomena as secondary events. There is a genetic predisposition, with first- and second-degree relatives often also affected. Bouts are often triggered by a disturbance of inherent biorhythms, such as late nights or early rises, stress, or winding down after stress at home or school. Certain foods, e.g. cheese, chocolate and caffeine, are only rarely a reliable trigger. In girls, headaches can be related to menstruation and the oral contraceptive pill.

Uncommon forms of migraine

These include:

• Familial – linked to a calcium channel defect, dominantly inherited

• Sporadic hemiplegic migraine

• Basilar-type migraine – vomiting with nystagmus and/or cerebellar signs

• Periodic syndromes – often precursors of migraine and include:

Secondary headaches

Raised intracranial pressure and space-occupying lesions

Headaches often raise the fear of brain tumours; it may well be the reason for parents to consult a doctor. Headaches due to a space-occupying lesion are worse when lying down and morning vomiting is characteristic. The headaches may also cause night-time waking. There is often a change in mood, personality or educational performance. Other features suggestive of a space-occupying lesion are:

• Visual field defects – from lesions pressing on the optic pathways, e.g. craniopharyngioma (a pituitary tumour)

• Cranial nerve abnormalities causing diplopia, new-onset squint or facial nerve palsy. The VIth (abducens) cranial nerve has a long intracranial course and is often affected when there is raised pressure, resulting in a squint with diplopia and inability to abduct the eye beyond the midline. It is a false localising sign. Other nerves are affected depending on the site of lesion, e.g. pontine lesions may affect the VIIth (facial) cranial nerve and cause a facial nerve palsy

• Abnormal gait

• Torticollis (tilting of the head)

• Growth failure, e.g. craniopharyngioma or hypothalamic lesion

• Papilloedema – a late feature

• Cranial bruits – may be heard in arteriovenous malformations but these lesions are rare.

Management

The mainstay of management is a thorough history and examination with detailed explanation and advice. Imaging is unnecessary in the absence of any Red Flag features.

Children and parents should be informed that recurrent headaches are common. For most there are good and bad spells, with periods of months or even years in between the bad spells, and that they cause no long-term harm. Written child-friendly information for the family to take home is helpful. Children should be advised on how to live with and control the headaches, rather than allowing the headaches to dominate their lives. There is nothing medicine can do to cure this problem but there is much it can offer to make the bad spells more bearable.

Seizures

A seizure is a clinical event in which there is a sudden disturbance of neurological function caused by an abnormal or excessive neuronal discharge. Seizures may be epileptic or non-epileptic.

The causes of seizures are listed in Box 27.2.

Febrile seizures

A febrile seizure is a seizure accompanied by a fever in the absence of intracranial infection due to bacterial meningitis or viral encephalitis. These occur in 3% of children, between the ages of 6 months and 5 years. There is a genetic predisposition, with a 10% risk if the child has a first-degree relative with febrile seizures. The seizure usually occurs early in a viral infection when the temperature is rising rapidly. The seizures are usually brief, and are generalised tonic-clonic seizures. About 30–40% will have further febrile seizures. This is more likely the younger the child, the shorter the duration of illness before the seizure, the lower the temperature at the time of seizure and if there is a positive family history.

Simple febrile seizures do not cause brain damage; the child’s subsequent intellectual performance is the same as in children who do not experience a febrile seizure. There is a 1–2% chance of developing epilepsy, similar to the risk for all children.

However, complex febrile seizures; i.e. those which are focal, prolonged, or repeated in the same illness, have an increased risk of 4–12% of subsequent epilepsy.

The acute management of seizures is described in Chapter 6. Examination should focus on the cause of the fever, which is usually a viral illness, but a bacterial infection including meningitis should always be considered. The classical features of meningitis such as neck stiffness and photophobia may not be as apparent in children <18 months of age, so an infection screen (including blood cultures, urine culture and lumbar puncture for CSF) may be necessary. If the child is unconscious or has cardiovascular instability, lumbar puncture is contraindicated and antibiotics should be started immediately.

Parents need reassurance and information. Advice sheets are usually given to parents. Antipyretics have not been shown to prevent febrile seizures and tepid sponging is no longer recommended. The family should be taught the first aid management of seizures. If there is a history of prolonged seizures (>5 min), rescue therapy with rectal diazepam or buccal midazolam can be supplied. Oral prophylactic anti-epileptic drugs are not used as they do not reduce the recurrence rate of seizures or the risk of epilepsy. An EEG is not indicated as it does not serve as a guide for treatment; nor does it predict seizure recurrence.

Paroxysmal disorders

There is a broad differential diagnosis for children with paroxysmal disorders (‘funny turns’). Epilepsy is a clinical diagnosis based on the history from eyewitnesses and the child’s own account. If available, videos of the seizures or suspected seizures can be of great help. The diagnostic question is whether the paroxysmal events are that of an epilepsy of childhood or one of the many conditions which mimic it (Fig. 27.1). The most common pitfall is that of syncope leading to an anoxic (non-epileptic) tonic-clonic seizure.

The key to the diagnosis lies in a detailed history, which, together with clinical examination, will determine the need for an EEG or other investigations.

Epilepsies of childhood

Epilepsy has an incidence of about 0.05% (after the first year of life when it is even more common) and a prevalence of 0.5%. This means that most large secondary schools will have about six children with an epilepsy. Epilepsy is a chronic neurological disorder characterised by recurrent unprovoked seizures, consisting of transient signs and/or symptoms associated with abnormal, excessive or synchronous neuronal activity in the brain. Most epilepsy is idiopathic but other causes of seizures are listed in Box 27.2.

An international classification of epilepsy is used, which has recently been revised (International League Against Epilepsy (ILAE) 2010 Classifications). This broadly classifies seizures as either:

Focal seizure manifestations will depend on the part of the brain where the discharge originates:

• Frontal seizures – involve the motor or premotor cortex. May lead to clonic movements, which may travel proximally (Jacksonian march). Asymmetrical tonic seizures can be seen, which may be bizarre and hyperkinetic and can be mistakenly dismissed as non-epileptic events. Atonic seizures may arise from mesial frontal discharge.

• Temporal lobe seizures, the most common of all the epilepsies – may result in strange warning feelings or aura with smell and taste abnormalities and distortions of sound and shape. Lip-smacking, plucking at one’s clothing and walking in a non-purposeful manner (automatisms) may be seen, following spread to the pre-motor cortex. Déjà-vu and jamais-vu are described (intense feelings of having been, or never having been, in the same situation before). Consciousness can be impaired and the length of event is longer than a typical absence.

• Occipital seizures – cause distortion of vision.

• Parietal lobe seizures – cause contralateral dysaesthesias (altered sensation), or distorted body image.

In focal seizures, the level of consciousness may be retained, consciousness may be lost, or the seizure may be followed by generalised tonic-clonic seizure. In the new classification, the terms, simple or complex or discognitive are no longer used and the impairment of consciousness is not classified but described.

In many children, especially under 5 years old, it may be unclear whether a seizure is generalised or focal.

The main seizure types are summarised in Figure 27.2 and the epilepsy syndromes in Table 27.1.

Table 27.1

Some epilepsy syndromes – arranged by age of onset

Name Age Seizure pattern Comments
West syndrome 4–6 months Violent flexor spasms of the head, trunk and limbs followed by extension of the arms (so-called ‘salaam spasms’). Flexor spasms last 1–2 s, often multiple bursts of 20–30 spasms, often on waking, but may occur many times a day.
May be misinterpreted as colic. Social interaction often deteriorates – a useful marker in the history
Many causes; two-thirds have underlying neurological cause. The EEG shows hypsarrhythmia, a chaotic pattern of high-voltage slow waves, and multi-focal sharp wave discharges (Fig. 27.3). Treatment is with vigabatrin or corticosteroids; good response in 30–40%, but unwanted effects are common.
Most will subsequently lose skills and develop learning disability or epilepsy
Lennox–Gastaut syndrome 1–3 years Multiple seizure types, but mostly drop attacks (astatic seizures), tonic seizures and atypical absences. Also neurodevelopmental arrest or regression and behaviour disorder Often other complex neurological problems or history of infantile spasms.
Prognosis is poor
Childhood absence epilepsy 4–12 years Stare momentarily and stop moving, may twitch their eyelids or a hand minimally. Lasts only a few seconds and certainly not longer than 30 s. Child has no recall except realises they have missed something and may look puzzled or say ‘pardon’ on regaining consciousness.
Developmentally normal but can interfere with schooling.
Accounts for only 2% of childhood epilepsy
Two-thirds are female.
The episodes can be induced by hyperventilation, the child being asked to blow on a piece of paper or windmill for 2–3 min, a useful test in the outpatient clinic. The EEG shows generalised 3/second spike and wave discharge, which is bilaterally synchronous during and sometimes between episodes (Fig. 27.4). Prognosis is good, with 95% remission in adolescence; 5–10% may develop tonic-clonic seizures in adult life
Benign* epilepsy, with centrotemporal spikes (BECTS) 4–10 years Tonic-clonic seizures in sleep, or simple focal seizures with awareness of abnormal feelings in the tongue and distortion of the face (supplied by the Rolandic area of the brain) Comprises 15% of all childhood epilepsies.
EEG shows focal sharp waves from the Rolandic or centrotemporal area. Important to recognise as it is benign and does not always require treatment. Almost all remit in adolescence
Early-onset benign* childhood occipital epilepsy (Panayiotopoulos type) 1–14 years Younger children – periods of unresponsiveness, eye deviation, vomiting and autonomic features. Older children – headache and visual disturbance including distortion of images and hallucinations Uncommon.
EEG shows occipital discharges. Remit in childhood
Juvenile myoclonic epilepsy Adolescence-adulthood Myoclonic seizures, but generalised tonic-clonic seizures and absences may occur, mostly shortly after waking. A typical history is throwing drinks or cornflakes about in the morning as myoclonus occurs at this time. Learning is unimpaired Characteristic EEG.
Response to treatment is usually good but lifelong.
A genetic linkage has been identified.
Remission unlikely

image

*Although called benign, may be specific learning difficulties in some children.

Investigation of seizures

EEG

An EEG is indicated whenever epilepsy is suspected. It is interpreted to identify a background that is abnormal for the child’s age; asymmetry or slowing that might suggest underlying structural abnormalities; or evidence of neuronal hyperexcitability such as sharp waves or spike-wave complexes. Many children with epilepsy have a normal initial EEG; and many children who will never have epilepsy have EEG abnormalities. Unless a seizure is actually captured, an EEG does no more than add supportive evidence (or not) for the diagnosis. If the standard EEG is normal, a sleep or sleep-deprived record can be helpful. Additional techniques are 24–h ambulatory EEG or, ideally, video-telemetry. For assessment prior to surgery, more invasive techniques such as subdural electrodes can be used.

Imaging

• Structural. MRI and CT brain scans are not required routinely for childhood generalised epilepsies. They are indicated if there are neurological signs between seizures, or if seizures are focal, in order to identify a tumour, vascular lesion, or area of sclerosis which could be treatable. MRI FLAIR (fluid-attenuated inversion recovery) sequences better detect mesial temporal sclerosis in temporal lobe epilepsy.

• Functional scans. While it is not always possible to see structural lesions, techniques have advanced to allow functional imaging to detect areas of abnormal metabolism suggestive of seizure foci. These include PET (positron emission tomography) and SPECT (single positron emission computed tomography), which use isotopes and ligands, injected and taken up by metabolically active cells. Both can be used between seizures to detect areas of hypometabolism in epileptogenic lesions. SPECT can also be used to capture seizures and areas of hypermetabolism. Functional MRI can be used alongside psychological testing –including memory assessment – to minimise the risk of postoperative impairment.

Management

Management begins with explanation and advice to help adjustment to the condition. A specialist epilepsy nurse may assist families by providing education and continuing advice on lifestyle issues. The decision whether to treat or not is related to the level of inconvenience seizures are bringing into the young person’s life. It is common practice not to institute treatment after a single unprovoked seizure.

Anti-epileptic drug (AED) therapy

Principles governing use are:

• Not all seizures require AED therapy. This decision should be based on the seizure type, frequency and the social and educational consequences of the seizures set against the possibility of unwanted effects of the drugs.

• Choose the appropriate drug for the seizure. Inappropriate AEDs may be detrimental, e.g. carbamazepine can make absence and myoclonic seizures worse.

• Monotherapy at the minimum dosage is the desired goal, although in practice more then one drug may be required.

• All AEDs have potential unwanted effects and these should be discussed with the child and parent.

• Drug levels are not measured routinely, but may be useful to check for adherence to advice or with some drugs with erratic pharmacokinetics, e.g. phenytoin.

• Children with prolonged seizures are given rescue therapy to keep with them. This is usually a benzodiazepine, e.g. rectal diazepam or buccal midazolam.

• AED therapy can usually be discontinued after 2 years free of seizures.

Guidance regarding treatment options for different seizure types are shown in Table 27.2. Common unwanted effects of AEDs are shown in Table 27.3.

Table 27.2

Choice of anti-epileptic drugs (NICE 2004)

Seizure type First-line Second-line
Generalised seizures    
 Tonic-clonic Valproate, carbamazepine Lamotrigine, topiramate
 Absence Valproate, ethosuximide Lamotrigine
 Myoclonic Valproate Lamotrigine
Focal seizures Carbamazepine, valproate
Lamotrigine shown since to be most effective – but slow titration
Topiramate, levetiracetam, oxcarbazepine, gabapentin, tiagabine, vigabatrin

Table 27.3

Common or important unwanted effects of anti-epileptic drugs

Drug Side-effects
Valproate Weight gain, hair loss
Rare idiosyncratic liver failure
Carbamazepine/oxcarbazepine Rash, neutropenia, hyponatraemia, ataxia
Liver enzyme induction, can interfere with other medication
Vigabatrin Restriction of visual fields, which has limited its use
Sedation
Lamotrigine Rash
Ethosuximide Nausea and vomiting
Topiramate Drowsiness, withdrawal and weight loss
Gabapentin Insomnia
Levetiracetam Sedation – rare
Benzodiazepines – clobazam, clonazepam, diazepam, nitrazepam Sedation, tolerance to effect, increased secretions

image

All the above may cause drowsiness and occasional skin rashes.

Other treatment options

In children with intractable seizures, there are a number of radical treatment options.

• Ketogenic (fat-based) diets may be helpful in some children. Its mechanism of action is poorly understood.

• Vagal nerve stimulation, delivered using externally programmable stimulation of a wire implanted around the vagal nerve, may possibly be useful; trials are being conducted.

• Surgery. Cessation of seizures and drug therapy may be achieved in some children whose clinical seizures are well-localised as demonstrated by good concordance between EEG, MRI and functional imaging findings. The main procedure is temporal lobectomy for mesial temporal sclerosis, but other procedures include hemispherectomy or hemispherotomy (isolation of hemisphere which is not removed so as avoid post-operative shifts in space) and other focal resections. Detailed assessment is required to ensure that the benefits outweigh the risks.

Advice and prognosis

The aim is to promote independence and confidence. Some children with epilepsy and their families need psychological help to adjust to the condition. The school needs to be aware of the child’s problem and teachers advised on the management of seizures. Unrecognised absences may interfere with learning, which is an indication for being vigilant about ‘odd episodes’ which may represent seizures. Relatively few restrictions are required, but situations where having a seizure could lead to injury or be fatal should be avoided. This includes avoiding deep baths (showers are preferable) and not swimming alone in deep water. Those with photosensitivity should sit at a distance from televisions, can cover one eye, and check that TVs and VDUs in use are acceptable (Epilepsy Action consider most modern TVs and VDUs to be suitable and can provide advice).

For adolescents, there may be issues to discuss around driving (only after 1 year free of seizures), contraception and pregnancy. There may also be issues with adherence and precipitation of seizures by alcohol and poor sleep routines.

Sudden unexpected death in epilepsy, SUDEP, may be discussed, and its low risks emphasised. Information is available from self-help groups and organisations such as Epilepsy Action.

Children with epilepsy do less well educationally, with social outcomes and with future employment than those with other chronic illnesses such as diabetes.

Two-thirds of children with epilepsy go to a mainstream school, but some require educational help for associated learning difficulties. One-third attend a special school, but they often have multiple disabilities and their epilepsy is part of a severe brain disorder. A few children require residential schooling where there are facilities and expertise in monitoring and treating intractable seizures.

Central motor disorders

The three central movement control centres are:

Disorders of these central movement control centres are:

• Corticospinal (pyramidal) tract disorders – there is weakness with a pattern of adduction at the shoulder, flexion at the elbow and pronation of the forearm; adduction and internal rotation at the hip, flexion at hip, knee and plantar flexion at the ankle with brisk hyper-reflexia and extensor plantars. Fine finger movement will be lost.

• Basal ganglia disorders – will lead either to difficulty initiating movement, with fluctuating (largely increased) tone – a ‘dystonia’, or a ‘dyskinesia’, where packets of movement information are released to give jerky movement (chorea) or writhing movement (athetosis).

• Cerebellar disorders – will lead to difficulty holding a posture (particularly with eyes closed); past-pointing (dysmetria); poor alternating movements (dysdiadochokinesis); and a characteristic scanning dysarthria. Posterior sensory pathway problems may give a similar clinical picture but are much rarer in childhood. The gait is wide-based. Associated nystagmus may be seen. Causes of these disorders are listed in Table 27.4.

image

Peripheral motor disorders: the neuromuscular disorders

Any part of the lower motor pathway can be affected in a neuromuscular disorder, so that anterior horn cell disorders, peripheral neuropathies, disorders of neuromuscular transmission and primary muscle diseases can all occur. The causes of neuromuscular disorders are shown in Figure 27.5. The key clinical feature of a neuromuscular disorder is weakness, which may be progressive or static. Affected children may present with:

History and examination may provide useful clues. Children with myopathy often show a waddling gait or positive Gowers sign suggestive of proximal muscle weakness. Gowers sign is the need to turn prone to rise to a standing from a supine position. This is normal until the age of 3 years. It is only when children have become very weak that they ‘climb up the legs with the hands’ to gain the standing position (Fig. 27.6). A pattern of more distal wasting and weakness, particularly in the presence of pes cavus, suggests an hereditary motor sensory neuropathy. Increasing fatiguability through the day, often with ophthalmoplegia and ptosis, would be more consistent with depletion at the motor end-plate and a diagnosis of myasthenia gravis.

It is usually difficult to differentiate a myopathy from a neuropathy on clinical grounds but there are some broad points to look for:

Investigations

Myopathy:

Neuropathy:

Diagnosis of neuromuscular disorders has been made easier by the advances made in confirmatory DNA tests for many of them, e.g. spinal muscular atrophy (SMA), Duchenne muscular dystrophy, myotonic dystrophy, the congenital muscular dystrophies and hereditary neuropathies. This also allows antenatal testing and genetic counselling and often obviates the need for the discomfort of peripheral neurophysiology.

Disorders of the anterior horn cell

Presentation is with weakness, wasting and absent reflexes. The features of poliomyelitis are described in Chapter 14.

Spinal muscular atrophy type 1 (Werdnig–Hoffmann disease)

A very severe progressive disorder presenting in early infancy (Fig. 27.7). Diminished fetal movements are often noticed during pregnancy and there may be arthrogryposis (positional deformities of the limbs with contractures of at least two joints) at birth. Typical signs include:

These children never sit unaided. Death is from respiratory failure within about 12 months. There are milder forms of the disorder with a later onset. Children with type 2 spinal muscular atrophy can sit, but never walk independently. Those with type 3 (Kugelberg–Welander) do walk and can present later in life.

Peripheral neuropathies

The hereditary motor sensory neuropathies (HMSN)

This group of disorders typically leads to symmetrical, slowly progressive muscular wasting, which is distal rather than proximal. Type I, formerly known as peroneal muscular atrophy (Charcot–Marie–Tooth disease), is usually dominantly inherited and the most common. Affected nerves may be hypertrophic due to demyelination followed by attempts at remyelination. Nerve biopsy typically shows ‘onion bulb formation’ due to these two processes. Onset is in the first decade with distal atrophy and pes cavus, the legs being affected more than the arms. Rarely, there may be distal sensory loss and the reflexes are diminished. The disease is chronic and only rarely do those affected lose the ability to walk. The initial presentation of Friedreich ataxia can be similar.

Acute post-infectious polyneuropathy (Guillain–Barré syndrome)

Presentation is typically 2–3 weeks after an upper respiratory tract infection or campylobacter gastroenteritis. There may be fleeting abnormal sensory symptoms in the legs, but the prominent feature is an ascending symmetrical weakness with loss of reflexes and autonomic involvement. Sensory symptoms, usually in the distal limbs, are less striking than the paresis but can be unpleasant. Involvement of bulbar muscles leads to difficulty with chewing and swallowing and the risk of aspiration. Respiratory depression may require artificial ventilation. The maximum muscle weakness may occur only 2–4 weeks after the onset of illness. Although full recovery may be expected in 95% of cases, this may take up to 2 years.

The CSF protein is characteristically markedly raised, but this may not be seen until the second week of illness. The CSF white cell count is not raised. Nerve conduction velocities are reduced.

Management of post-infectious polyneuropathy is supportive, particularly of respiration. The disorder is probably due to the formation of antibody attaching itself to protein components of myelin. Corticosteroids have no beneficial effect and may delay recovery. Controlled trials indicate the ventilator-dependent period can be significantly reduced by immunoglobulin infusion. If this is not successful, plasma exchange may be effective.

Bell palsy and facial nerve palsies

Bell palsy is an isolated lower motor neurone paresis of the VIIth cranial nerve leading to facial weakness (Fig. 27.8). Although the aetiology is unclear, it is probably post-infectious with an association with herpes simplex virus in adults. Corticosteroids may be of value in reducing oedema in the facial canal during the first week; no benefit from aciclovir has been demonstrated. Recovery is complete in the majority of cases but may take several months. The main complication is conjunctival infection due to incomplete eye closure on blinking. This may require the eye to be protected with a patch or even tarsorrhaphy.

There is an important differential diagnosis. If symptoms of an VIIIth nerve paresis are also present then the most likely diagnosis is a compressive lesion in the cerebellopontine angle. The herpes virus may invade the geniculate ganglion and give painful vesicles on the tonsillar fauces and external ear, along with a facial nerve paresis. Treatment for this is with aciclovir.

Hypertension should be excluded, as there is an association between Bell palsy and coarctation of the aorta. If the facial weakness is bilateral, sarcoidosis should be suspected, and this is also seen in Lyme disease.

Disorders of neuromuscular transmission

Myasthenia gravis

This presents as abnormal muscle fatiguability which improves with rest or anticholinesterase drugs.

Juvenile myasthenia

This is similar to adult autoimmune myasthenia and is due to binding of antibody to acetylcholine receptors on the post-junctional synaptic membrane. This gives a reduction of the number of functional receptors. Presentation is usually after 10 years of age with ophthalmoplegia and ptosis, loss of facial expression and difficulty chewing (Fig. 27.9). Generalised, especially proximal, weakness may be seen.

Diagnosis is made by observing improvement following the administration of intravenous edrophonium and can be further confirmed by testing for acetylcholine receptor antibodies (seen in 60–80%) or, more rarely, anti-muscle-specific kinase (anti-MuSK) antibodies. Treatment is with the anti-muscarinic drugs neostigmine or pyridostigmine. In the longer term, immunosuppressive therapy with prednisolone or azathioprine is of value. Plasma exchange is used for crises. Thymectomy is considered if a thymoma is present or if the response to medical therapy is unsatisfactory. About a quarter will show remission post thymectomy and up to half show some improvement.

Muscle disorders

The muscular dystrophies

This is a group of inherited disorders with muscle degeneration, often progressive.

Duchenne muscular dystrophy

Duchenne muscular dystrophy is the most common phenotype, affecting 1 in 4000 male infants. It is inherited as an X-linked recessive disorder, although about a third have new mutations. It results from a deletion on the short arm of the X chromosome (at the Xp21 site). This site codes for a protein called dystrophin, which connects the cytoskeleton of a muscle fibre to the surrounding extracellular matrix through the cell membrane. Where it is deficient, there are several aberrant intracellular signalling pathways associated with an influx of calcium ions, a breakdown of the calcium calmodulin complex and an excess of free radicals, ultimately leading to myofibre necrosis. The serum creatine phosphokinase (CPK) is markedly elevated. Some countries, e.g. Wales, have introduced neonatal screening for Duchenne dystrophy; affected children are detected in the neonatal screening test by an elevated CPK.

Children present with a waddling gait and/or language delay; they have to mount stairs one by one and run slowly compared to their peers. Although the average age of diagnosis remains 5.5 years, children often become symptomatic much earlier. They will show Gowers sign (the need to turn prone to rise). There is pseudohypertrophy of the calves because of replacement of muscle fibres by fat and fibrous tissue.

In the early school years, affected boys tend to be slower and clumsier than their peers. The progressive muscle atrophy and weakness means that they are no longer ambulant by the age of about 10–14 years. Life expectancy is reduced to the late twenties from respiratory failure or the associated cardiomyopathy. About one-third of affected children have learning difficulties. Scoliosis is a common complication.

Management – Appropriate exercise helps to maintain muscle power and mobility and delays the onset of scoliosis. Contractures, particularly at the ankles, should be prevented by passive stretching and the provision of night splints. Walking can be prolonged with the provision of orthoses, in particular those which allow ambulation by leaning from side to side. Lengthening of the Achilles tendon may be required to facilitate ambulation. Attention to maintaining a good sitting posture helps to minimise the risk of scoliosis. Scoliosis is managed with a truncal brace, a moulded seat and ultimately surgical insertion of a metal spinal rod. Later in the condition, episodes of nocturnal hypoxia secondary to weakness of the intercostal muscles may present with lassitude or irritability. Respiratory aids, particularly overnight CPAP (continuous positive airway pressure) or non-invasive positive pressure ventilation (NIPPV), may be provided to improve the quality of life. As with all chronic disabling conditions, parent self-help groups are a useful continuing source of information and support for families. Affected children should be reviewed periodically at a specialist regional centre. Ambulant children with Duchenne dystrophy are increasingly treated with corticosteroids (prednisolone for 10 days each month) to preserve mobility and prevent scoliosis. The precise mechanism by which glucocorticoids may help is not known.

It may be possible to identify female carriers if they have a mildly raised CPK or if the gene deletion can be detected on DNA analysis. Antenatal diagnosis is then possible.

Metabolic myopathies

Metabolic conditions can affect muscles, due either to the deposition of storage material or to energy-depleting enzyme deficiencies. Presentation is as a floppy infant or, in older children, with muscle weakness or cramps on exercise. The main causes are:

The inflammatory myopathies

Dermatomyositis

This is a systemic illness, probably due to an angiopathy. Usual onset is between 5 and 10 years. This can be acute, but more typically is insidious with fever, misery, and eventually symmetrical muscle weakness, which is mainly proximal. Sometimes pharyngeal muscle involvement affects swallowing. There is also a characteristic violaceous (heliotrope) rash to the eyelids, and periorbital oedema (Fig. 27.10). The rash may also affect the extensor surfaces of joints, e.g. elbow, and with time subcutaneous calcification can appear. Inflammatory markers (CRP, ESR) can be raised but not invariably. Muscle biopsy shows an inflammatory cell infiltrate and atrophy. Physiotherapy is needed to prevent contractures. Corticosteroids are the standard treatment, and continue at a tailored dose for 2 years. Other immunosuppressants, e.g. methotrexate, ciclosporin, may be needed. Mortality is 5–10%.

Myotonic disorders

Myotonia is delayed relaxation after sustained muscle contraction. It can be identified clinically and on electromyography.

Dystrophia myotonica

This relatively common illness is dominantly inherited and caused by a nucleotide triplet repeat expansion, so this means there can be anticipation through generations, especially when maternally transmitted (see Ch. 8). Newborns can present with hypotonia and feeding and respiratory difficulties due to muscle weakness. It is then useful to examine the mother for myotonia. This manifests as slow release of handshake or difficulty releasing the tightly clasped fist. This may be mild and not have been appreciated. Sensitivity is required as diagnosis in the neonate may have repercussions for the family. Older children can present with myopathic facies (Fig. 27.11), learning difficulties and myotonia. Adults develop cataracts and males develop baldness and testicular atrophy. Death is usually due to cardiomyopathy.

The ‘floppy infant’

Persisting hypotonia in infants can be readily felt on picking up the infant, who tends to slip through the fingers or hang like a rag doll when suspended prone. There will be marked head lag when the head is lifted by the arms from supine. The causes are listed in Box 27.3. The clinical examination may help determine the site of the lesion, whether cortical or neuromuscular. Central hypotonia is associated with poor truncal tone but preserved limb tone. Dysmorphic features suggest a genetic cause. Lower motor neurone lesions are suggested by a frog-like posture (Fig. 27.7), poor antigravity movements and absent reflexes.

Ataxia

Friedreich ataxia

This is an autosomal recessive condition. The gene mutation (Frataxin) is an example of a trinucleotide repeat disorder. It presents with worsening ataxia, distal wasting in the legs, absent lower limb reflexes but extensor plantar responses because of pyramidal involvement, pes cavus and dysarthria. This is similar to the hereditary motor sensory neuropathies, but in Friedreich ataxia, there is impairment of joint position and vibration sense, extensor plantars and there is often optic atrophy. The cerebellar component becomes more apparent with age. Evolving kyphoscoliosis and cardiomyopathy can cause cardiorespiratory compromise and death at 40–50 years.

Ataxia telangiectasia

This disorder of DNA repair is an autosomal recessive condition. The gene (ATM) has been identified. There may be mild delay in motor development in infancy and oculomotor problems with incoordination and delay in ocular pursuit of objects (oculomotor dyspraxia), with difficulty with balance and coordination becoming evident at school age. There is subsequent deterioration, with a mixture of dystonia and cerebellar signs. Many children require a wheelchair for mobility in early adolescence. Telangiectasia develops in the conjunctiva (Fig. 27.12), neck and shoulders from about 4 years of age. These children:

Cerebrovascular disease

Intracranial haemorrhage

Extradural haemorrhage

This usually follows direct head trauma, often associated with skull fracture (tearing of middle meningeal artery as it passes through the foramen spinosum of the sphenoid bone). It results from arterial or venous bleeding into the extradural space. There is often a lucid interval until the conscious level deteriorates, with seizures, secondary to increasing size of the haematoma. There may be focal neurological signs with dilatation of the ipsilateral pupil, paresis of the contralateral limbs and a false localising uni- or bilateral VIth nerve paresis. In young children, initial presentation may be with anaemia and shock. The diagnosis is confirmed with a CT scan. Management is to correct hypovolaemia, urgent evacuation of the haematoma and arrest of the bleeding.

Stroke

Infantile stroke is dealt with in Chapter 10. Childhood stroke may be due to vascular, thromboembolic or haemorrhagic disease. The clinical presentation is determined by the vascular territory involved. There is compromise of the anterior circulation (internal carotid, anterior and middle cerebral arteries), which leads to hemiparesis with or without speech disturbance. Less common is compromise of the posterior circulation (vertebrobasilar arteries) with associated visual or cerebellar signs.

Causes include:

• Cardiac: congenital cyanotic heart disease, e.g. Fallot tetralogy, endocarditis

• Haematological: sickle cell disease; deficiencies of anti-thrombotic factors, e.g. protein S

• Post-infective: following varicella or other viral infection

• Inflammatory: damage to vessels in autoimmune disease, e.g. SLE (systemic lupus erythematosus)

• Metabolic/genetic: homocystinuria, mitochondrial disorders, e.g. MELAS (myoclonic epilepsy, lactic acidosis and stroke); CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), the most common form of hereditary stroke disorder

• Vascular malformations: moyamoya disease. These children have abnormal vasculature. Moyamoya comes from the Japanese for ‘puff of smoke’, similar to the blurred appearance seen on angiography.

Investigations should include an assessment of cerebral vasculature with MRI and MRA and carotid Doppler studies to rule out dissection of the carotid arteries (formal angiography may be required later); echocardiography to detect a source of embolism, along with a thrombophilia and vasculitis screen, and metabolic tests for homocysteine and mitochondrial cytopathy. Often no cause can be identified. Rehabilitation requires the involvement of the remedial therapy team. Aspirin prophylaxis is recommended but further evidence is needed on the advisability of anti-thrombolytic agents.

Neural tube defects and hydrocephalus

Neural tube defects

Neural tube defects result from failure of normal fusion of the neural plate to form the neural tube during the first 28 days following conception. Their birth prevalence in the UK has fallen dramatically from 4 per 1000 live births in the 1970s to 0.15 per 1000 live births in 1998 and to 0.11 per 1000 live births in 2005 (Fig. 27.13). This is mainly because of a natural decline, as well as antenatal screening.

The reason for the natural decline is uncertain, but may be associated with improved maternal nutrition. Mothers of a fetus with a neural tube defect have a 10-fold increase in risk of having a second affected fetus. Folic acid supplementation reduces this risk. High doses are now recommended periconceptually for women with a previously affected infant planning a further pregnancy. Low-dose periconceptual folic acid supplementation is recommended for all pregnancies. In some countries e.g. United States, folic acid is added to flour for bread.

Spina bifida occulta

This failure of fusion of the vertebral arch (Fig. 27.14a) is often an incidental finding on X-ray, but there may be an associated overlying skin lesion such as a tuft of hair, lipoma, birth mark or small dermal sinus, usually in the lumbar region. There may be underlying tethering of the cord (diastematomyelia), which, with growth, may cause neurological deficits of bladder function and lower limbs. The extent of the underlying lesion can be delineated using ultrasound and/or MRI scans. Neurosurgical relief of tethering is usually indicated.

Meningocele and myelomeningocele

Meningoceles (Fig. 27.14b) usually have a good prognosis following surgical repair.

Myelomeningoceles (Figs 27.14c, 27.15) may be associated with:

Management – The back lesion is usually closed soon after birth.

Paralysis and muscle imbalance – physiotherapy helps prevent joint contractures. Walking aids or a wheelchair help mobility.

For sensory loss – skin care is required to avoid the development of skin damage and ulcers.

Neuropathic bladder – an indwelling catheter may be required for a neurogenic bladder, or intermittent urinary catheterisation may be performed by parents or by older children themselves. There should be regular checks for hypertension, renal function and urinary infection. Prophylactic antibiotics may be necessary. Medication (such as ephedrine or oxybutynin) may improve bladder function and improve urinary dribbling.

Bowel denervation – requires regular toileting, and laxatives and suppositories are likely to be necessary with a low roughage diet for lesions above L3.

Scoliosis – is monitored and may require surgical treatment. Ventricular dilatation associated with a Chiari malformation – often present at birth and 80% of affected infants require a shunt for progressive hydrocephalus during the first few weeks of life.

The most severely disabled have a spinal lesion above L3 at birth. They are unable to walk, have a scoliosis, neuropathic bladder, hydronephrosis and frequently develop hydrocephalus.

Modern medical care has improved the quality of life for severely affected children. Their care is best managed by a specialist multidisciplinary team.

Hydrocephalus

In hydrocephalus, there is obstruction to the flow of cerebrospinal fluid, leading to dilatation of the ventricular system proximal to the site of obstruction. The obstruction may be within the ventricular system or aqueduct (non-communicating or obstructive hydrocephalus), or at the arachnoid villi, the site of absorption of CSF (communicating hydrocephalus) (Box 27.4).

Clinical features

In infants with hydrocephalus, as their skull sutures have not fused, the head circumference may be disproportionately large or show an excessive rate of growth. The skull sutures separate, the anterior fontanelle bulges and the scalp veins become distended. An advanced sign is fixed downward gaze or sun setting of the eyes (Fig. 27.16). Older children will develop signs and symptoms of raised intracranial pressure.

Hydrocephalus may be diagnosed on antenatal ultrasound screening or in preterm infants on routine cranial ultrasound scanning. For suspected hydrocephalus, initial assessment is with cranial ultrasound (in infants) or imaging with CT or MRI. Head circumference should be monitored over time on centile charts.

Treatment is required for symptomatic relief of raised intracranial pressure and to minimise the risk of neurological damage. The mainstay is the insertion of a ventriculoperitoneal shunt (Fig. 27.17), but endoscopic treatment to create a ventriculostomy can now be performed. Shunts can malfunction due to blockage or infection (usually with coagulase-negative staphylococci). They then need replacing or revising. Overdrainage of fluid can cause low-pressure headaches but the insertion of regulatory valves can help avoid this.

The neurocutaneous syndromes

The nervous system and the skin have a common ectodermal origin. Embryological disruption causes syndromes involving abnormalities to both systems – the neurocutaneous syndromes.

Neurofibromatosis type 1 (NF1)

This affects 1 in 3000 live births. It is an autosomal dominant, highly penetrant condition. One-third have new mutations. The gene has been identified.

In order to make the diagnosis, two or more of these criteria need to be present:

The cutaneous features tend to become more evident after puberty, and there is a wide spectrum of involvement from mild to severe. Neurofibromata appear in the course of any peripheral nerve, including cranial nerves. They may look unsightly or cause neurological signs if they occur at a site where a peripheral nerve passes through a bony foramen. Visual or auditory impairment may result if there is compression of the IInd or VIIIth cranial nerve. Megalencephaly with learning difficulties and epilepsy are sometimes seen.

Neurofibromatosis type 2 (NF2; bilateral, acoustic or central) is less common and presents in adolescence. Bilateral acoustic neuromata are the predominant feature and present with deafness and sometimes a cerebellopontine angle syndrome with a facial (VIIth) nerve paresis and cerebellar ataxia.

There may be an overlap between the features of NF1 and NF2. Both NF1 and NF2 can be associated with endocrinological disorders, the multiple endocrine neoplasia (MEN) syndromes.

Other associations are phaeochromocytoma, pulmonary hypertension, renal artery stenosis with hypertension, and gliomatous change, particularly in central nervous system lesions. Rarely, the benign tumours undergo sarcomatous change. However, most people with the disorder carry no features other than the cutaneous stigmata.

Tuberous sclerosis

This disorder is a dominantly inherited disorder, but up to 70% are new mutations. Prevalence is 1 in 9000 live births.

The cutaneous features consist of:

Neurological features are:

These children have severe learning difficulties and often have autistic features to their behaviour when older. Other features are:

As with neurofibromatosis, gliomatous change can occur in the brain lesions. Many people who carry the gene have no stigmata other than the cutaneous features and no associated neurological features.

CT scans will detect the calcified subependymal nodules and tubers from the second year of life. MRI is more sensitive and more clearly identifies other tubers and lesions.

Sturge–Weber syndrome

This is a sporadic disorder with a haemangiomatous facial lesion (a port-wine stain) in the distribution of the trigeminal nerve associated with a similar lesion intracranially. The ophthalmic division of the trigeminal nerve is always involved (Fig. 27.20). Calcification of the gyri used to show characteristic ‘rail-road track’ calcification on skull X-ray, but MRI is the imaging modality of choice nowadays. In the most severe form, it may present with epilepsy, learning disability and hemiplegia. Children presenting with intractable epilepsy in early infancy may benefit from hemispherectomy. For children who are less severely affected, deterioration is unusual after the age of 5 years, although there may still be seizures and learning difficulties. There is a high risk of glaucoma, which should be assessed in the neonatal period.

Neurodegenerative disorders

These are disorders that cause a deterioration in motor and intellectual function. Abnormal neurological features develop, including seizures, spasticity, abnormal head circumference (macro- or microcephaly), involuntary movement disorders, visual and hearing loss and behaviour change. While individually rare, they are numerous and include:

• Lysosomal storage disorders, e.g. lipid storage disorders and mucopolysaccharidoses, in which absence of an enzyme leads to accumulation of a harmful metabolite

• Peroxisomal enzyme defects, e.g. X-linked adrenoleucodystrophy. Peroxisomes are catalase- and oxidase-containing organelles involved in long-chain fatty acid oxidation. Enzyme deficiencies can lead to accumulation of very long-chain fatty acids (VLCFAs)

• Heredodegenerative disorders, e.g. Huntington disease, which presents with progressive dystonia, dementia, seizures and corticospinal tract signs

• Wilson disease, from the accumulation of copper, may cause changes in behaviour and additional involuntary movements or a mixture of neurological and hepatic symptoms

• Subacute sclerosing panencephalitis (SSPE), a delayed response in adolescence to previous measles infection causing neurological regression with a characteristic EEG, but has become rare since measles immunisation.

Lysosomal storage disorders

In metachromatic leucodystrophy, a sulfatidosis, an accumulation of sulphatides causes a destruction of myelin and is diagnosed on testing white cell enzymes.

In lipid storage disorders (Table 27.5), which are sphingolipidoses, there is an accumulation of sphingolipids, essential components of CNS membranes. They are diagnosed on testing white cell enzymes.

Table 27.5

Lipid storage disorders

Disorder Enzyme defect Clinical features
Tay–Sachs disease Hexosaminidase A Autosomal recessive disorder
Most common among Ashkenazi Jews
Developmental regression in late infancy, exaggerated startle response to noise, visual inattention and social unresponsiveness
Severe hypotonia, enlarging head
Cherry red spot at the macula
Death by 2–5 years
Diagnosis – measurement of the specific enzyme activity
Carrier detection of high-risk couples is practised
Prenatal detection is possible
Gaucher disease Beta-glucosidase Occurs in 1 in 500 Ashkenazi Jews
Chronic childhood form – splenomegaly, bone marrow suppression, bone involvement, normal IQ
Splenectomy may alleviate hypersplenism
Enzyme replacement therapy is available, but is expensive
Acute infantile form – splenomegaly, neurological degeneration with seizures
Carrier detection and prenatal diagnosis are possible
Niemann–Pick disease Sphingomyelinase At 3–4 months, feeding difficulties and failure to thrive, hepatosplenomegaly, developmental delay, hypotonia and deterioration of hearing and vision
Cherry red spot in macula affects 50%
Death by 4 years

image

The mucopolysaccharidoses are progressive multisystem disorders which may affect the neurological, ocular, cardiac and skeletal systems (Table 27.6). Hepatosplenomegaly is usually present. Most children present with developmental delay following a period of essentially normal growth and development up to 6–12 months of age. Developmental attainment then slows and children may show some loss of skills. It is only in the second 6 months of life that the characteristic facies begin to emerge, with coarsening of the facial features and prominent forehead due to frontal bossing (Fig. 27.21).

Mucopolysaccharidoses

Table 27.6

Clinical features of mucopolysaccharidoses

Eyes Corneal clouding
Retinal degeneration
Glaucoma
Skin Thickened skin
Coarse facies
Heart Valvular lesions
Cardiac failure
Neurology Developmental regression
Skeletal Thickened skull
Broad ribs
Claw hand
Thoracic kyphosis
Lumbar lordosis
Other Hepatosplenomegaly
Carpal tunnel syndrome
Conductive deafness
Umbilical and inguinal hernias

image

Table 27.7

Types of mucopolysaccharidoses

Type Inheritance Cornea Heart Brain Skeletal
MPS I (Hurler) AR +++ ++ +++ ++
MPS II (Hunter) X-linked + ++ +
MPS III (Sanfilippo) AR ± + +
MPS IV (Morquio) AR + + +++
MPS VI (Maroteaux–Lamy) AR +++ ++ ++

image

AR, autosomal recessive.

The characteristics of five of the varieties are shown in Table 27.7. The diagnosis is made by identifying the enzyme defect and the excretion in the urine of the major storage substances, the glycosaminoglycans (GAGs). Treatment is supportive according to the child’s needs. Successful enzyme replacement by bone marrow transplantation has been performed but cannot reverse any established neurological abnormality.

Share this: